SV

Street Verdict

Analyst Scorecard

SUNPHARMA · NSE

Sun Pharmaceutical Industries Limited

₹1,884.9

-0.79% (-₹15.1)

Prev. close

₹1,900

Volume

19,16,054

Delivery %

57.5%

As of

20 Nov 2026

Price history

₹1,884.9+₹9.8 (+0.52%) · 3M
18 Aug 2026 → 20 Nov 2026
1,7501,8001,8501,9001,95018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

Analysts lean bullish

7 analyst stances · last 90 days · one per analyst

Trackable

7 · 7 bull / 0 neutral / 0 bear

Long-Horizon

none in range

Commentary

none in range

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (7)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 22 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Details

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Dilip Shantilal Shanghvi

Headquarters

Mumbai

Employees

47,000

Key stats

Market cap

₹4.30 L Cr

P/E ratio (TTM)

39.3

Dividend yield

0.90%

EPS (TTM)

₹45.70

Beta (1Y · daily vs NIFTY 50)

0.43

Beta (5Y · monthly vs NIFTY 50)

0.85

Shares float

83.05 Cr

EPS · quarter ended Sept 2026

₹8.30

Upcoming earnings

28 Jan 2027

Financial Performance

01 · Financials

0 Cr20000 Cr40000 Cr60000 Cr₹0%10%20%30%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

0204060₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

051015₹-100%0%100%200%17 Feb 2019 Aug 2009 Feb 2123 Aug 2109 Feb 2219 Aug 2208 Feb 2328 Jul 2309 Feb 2412 Jul 2406 Feb 2507 Jul 2505 Feb 2607 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-10%0%10%20%FY21FY22FY23FY24FY25FY26
SalesFixed assetsReceivables (trade + unbilled)Inventory

05 · Capital Structure & Asset Utilization

0 L Cr0.5 L Cr1 L Cr1.5 L Cr₹0×0.2×0.4×0.6×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 L Cr0.5 L Cr1 L Cr1.5 L Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

0 Cr5000 Cr10000 Cr15000 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹33,498.14 Cr₹38,654.49 Cr₹43,885.68 Cr₹48,496.85 Cr₹52,578.44 Cr₹58,462.04 Cr
EBITDA
₹5,020.75 Cr₹6,752.41 Cr₹12,109.86 Cr₹13,883.00 Cr₹16,558.88 Cr₹18,395.64 Cr
₹2,903.82 Cr₹3,272.73 Cr₹8,473.58 Cr₹9,576.38 Cr₹10,929.04 Cr₹11,479.42 Cr
Diluted EPS
₹12.1₹13.6₹35.3₹39.9₹45.6₹47.8

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹67,666.73 Cr₹69,807.77 Cr₹80,743.59 Cr₹85,462.88 Cr₹92,100.58 Cr₹1.09 L Cr
₹3,868.58 Cr₹1,290.30 Cr₹6,885.87 Cr₹3,273.67 Cr₹2,362.19 Cr₹4,627.32 Cr
Stockholders' equity
₹46,462.78 Cr₹48,011.22 Cr₹55,995.38 Cr₹63,666.75 Cr₹72,218.02 Cr₹83,570.09 Cr

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹6,170.37 Cr₹8,984.54 Cr₹4,959.33 Cr₹12,134.98 Cr₹14,072.09 Cr₹12,419.18 Cr
Investing cash flow
₹536.22 Cr₹-5,724.74 Cr₹-7,943.68 Cr₹-690.20 Cr₹-5,306.16 Cr₹-11,344.05 Cr
₹-5,980.48 Cr₹-5,193.46 Cr₹2,376.07 Cr₹-6,710.16 Cr₹-7,905.82 Cr₹-2,512.55 Cr
Capital expenditure
₹-1,170.13 Cr₹-1,495.04 Cr₹-2,085.58 Cr₹-2,201.81 Cr₹-2,128.58 Cr₹-3,609.37 Cr
End cash position
₹6,273.03 Cr₹4,508.25 Cr₹4,623.73 Cr₹9,285.65 Cr₹10,268.77 Cr₹9,770.51 Cr

Debt issued, Debt repaid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21–Jun 26(20Q)
Promoter54.48%
Public45.52%
Employee trusts0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Lupin Limited₹92,244.53 Cr₹2,008.616.74.1123.8%0.29+23.9%+0.6%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

SUNPHARMA

Sun Pharmaceutical Industries Share Price Today Gains 2.17%

Univest · 4 days ago

SUNPHARMA

Sun Pharmaceutical Industries sales rise 11.8% to INR161,000 million

Multibagg AI · 18 days ago